As of Oct 26
| -0.01 / -0.66%|
The 5 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +366.67% increase from the last price of 1.50.
The current consensus among 5 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.